Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy

References

• Boyd N, Dancey JE, Gilks CB, et al. Rare cancers: a sea of opportunity. Lancet Oncol. 2016;17(2):e52–e61.
   PubMed Web of Science ®Google Scholar
• Lau K, Massad M, Pollak C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011;140(5):1312–1318.
   PubMed Web of Science ®Google Scholar
• Shiba S, Imaoka H, Shioji K, et al. Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study. BMC Cancer. 2018;18(1):993.
   PubMed Web of Science ®Google Scholar
• Rosenbaum E, Jadeja B, Xu B, et al. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets. Mod Pathol. 2020;33(4):591–602.
   PubMed Web of Science ®Google Scholar
• Deyrup AT, Tighiouart M, Montag AG, et al. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32(6):924–927.
   PubMed Web of Science ®Google Scholar
• Yousaf N, Harris S, Martin-Liberal J, et al. First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma. Clin Sarcoma Res. 2015;5:10.
   PubMed Web of Science ®Google Scholar
• Sardaro A, Bardoscia L, Petruzzelli MF, et al. Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev. 2014;8(2):259.
   PubMedGoogle Scholar
• Davis AT, Guo AM, Phillips NJ, et al. A novel treatment for bone lesions of multifocal epithelioid sarcoma-like hemangioendothelioma. Skeletal Radiol. 2015;44(7):1013–1019.
   PubMed Web of Science ®Google Scholar
• Thomas RM, Aloia TA, Truty MJ, et al. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB. 2014;16(7):677–685.
   PubMed Web of Science ®Google Scholar
• Jung DH, Hwang S, Hong SM, et al. Clinicopathological features and prognosis of hepatic epithelioid hemangioendothelioma after liver resection and transplantation. Ann Transplant. 2016;21:784–790.
   PubMed Web of Science ®Google Scholar
• Maruzzo M, Martin-Liberal J, Messiou C, et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience. Clin Sarcoma Res. 2015;5(1):5–80.
   PubMedGoogle Scholar
• Stacchiotti S, Provenzano S, Dagrada G, et al. Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the italian rare cancer network database. Ann Surg Oncol. 2016;23(9):2735–2744.
   PubMed Web of Science ®Google Scholar
• van de Poll-Franse LV, , Horevoorts N, van Eenbergen M, et al.; Profiles Registry Group. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188–2194.
   PubMed Web of Science ®Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–163.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29(1):89–96.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.eortc.be/itemlibrary/. [Last accessed on April 2017].
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
   PubMed Web of Science ®Google Scholar
• Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–592.
   PubMed Web of Science ®Google Scholar
• Vermunt JMJ. Latent GOLD 4.0 User’s Guide. Belmont (MA): Statistical Innovations; 2005.
   Google Scholar
• Nolte S, EORTC Quality of Life Group, Liegl G, Petersen MA, et al. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. Eur J Cancer. 2019;107:153–163.
   PubMed Web of Science ®Google Scholar
• Rosenberg A, Agulnik M. Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment. Curr Treat Options Oncol. 2018;19(4):19.
   PubMed Web of Science ®Google Scholar
• Wu X, Li B, Zheng C, et al. Clinical characteristics of epithelioid hemangioendothelioma: a single-center retrospective study. Eur J Med Res. 2019;24(1):16.
   PubMed Web of Science ®Google Scholar
• Kjaer TK, Johansen C, Ibfelt E, et al. Impact of symptom burden on health related quality of life of cancer survivors in a Danish cancer rehabilitation program: a longitudinal study. Acta Oncol. 2011;50(2):223–232.
   PubMed Web of Science ®Google Scholar
• Raijmakers NJH, Zijlstra M, van Roij J, et al. Health-related quality of life among cancer patients in their last year of life: results from the PROFILES registry. Support Care Cancer. 2018;26(10):3397–3404.
   PubMed Web of Science ®Google Scholar
• Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014;23(2):121–130.
   PubMed Web of Science ®Google Scholar
• Barsevick AM. The elusive concept of the symptom cluster. Oncol Nurs Forum. 2007;34(5):971–980.
   PubMed Web of Science ®Google Scholar
• Kirkova J, Walsh D, Aktas A, et al. Cancer symptom clusters: old concept but new data. Am J Hosp Palliat Care. 2010; Jun 27(4):282–288.
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, Lo C, Li M, et al. The relationship between depression and physical symptom burden in advanced cancer. BMJ Support Palliat Care. 2015;5(4):381–388.
   PubMed Web of Science ®Google Scholar
• Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004;22(3):507–516.
   PubMed Web of Science ®Google Scholar
• Sheinfeld Gorin S, Krebs P, Badr H, et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. JCO. 2012;30(5):539–547.
   PubMed Web of Science ®Google Scholar
• Syrjala KL, Jensen MP, Mendoza ME, et al. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703–1711.
   PubMed Web of Science ®Google Scholar
• Goedendorp MM, Gielissen MF, Verhagen CA, et al. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;(1):CD006953.
   PubMed Web of Science ®Google Scholar
• Li M, Kennedy EB, Byrne N, et al. Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer. Psychooncology. 2017;26(5):573–587.
   PubMed Web of Science ®Google Scholar